ArticleAnnals of medicine2026
Reference intervals for reproductive hormones in Chinese children aged 0-14 years based on the PRINCE study.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe concentrations of reproductive hormones considerably change during growth and development. Establishing accurate age- and sex-specific reference intervals for these hormones is important for monitoring development during childhood. Therefore, this study used data from the Paediatric Reference Intervals in China (PRINCE) study to establish and validate reference intervals (RIs) for sex and reproductive hormones in Chinese children. MATERIALS AND
methodsThis study is based on healthy children and adolescents from the PRINCE cohort. Serum samples were collected to determine age- and sex-specific RIs for luteinizing hormone, follicle-stimulating hormone, testosterone, oestradiol, progesterone and prolactin using a non-parametric method recommended by the Clinical and Laboratory Standards Institute guidelines.
resultsThe study included 1,707 healthy children (819 males and 888 females). Paediatric RIs for six reproductive hormones were established and stratified into distinct age and sex partitions. Key hormonal surges marked pubertal transition: in females, the upper limit of oestradiol more than doubled at age 9 years, while follicle-stimulating hormone began rising at age 8 years. In males, the upper limit of testosterone increased several-fold at age 11 years. Luteinizing hormone rose from age 9 in both sexes. Prolactin remained stable from ages 1-14, while progesterone increased in females after age 11. The RIs were successfully validated in 280 samples.
conclusionThis study is the first to establish and validate RIs for sex and reproductive hormones in Chinese children aged 0-14 years, thereby providing evidence-based support for interpreting laboratory test results and establishing clinical standards for paediatric endocrine disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.